← Latest news 
Trump announces Regeneron deal to cut Medicaid prices and slash Praluent cost
Economy
Published on 24 April 2026
A cholesterol drug hits just 225 dollars online
Trump has unveiled a deal with Regeneron aimed at lowering US healthcare costs under the most-favored-nation push. The company will cut prices for its drugs on Medicaid, and Praluent, a cholesterol medicine, is set to be sold for $225 on Trump’s discounted drug website. Regeneron also pledges major investment in US research and development.
- Regeneron will reduce prices for its drugs on Medicaid
- Praluent is priced at $225 on a Trump discounted drug site
- Deal is framed as part of the most-favored-nation initiative
- Company commits to significant US research and development investment
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times